Safety of a weekly administration of 7.5 mg/kg of liposomal amphotericin B for antifungal prophylaxis in patients receiving high-dose corticosteroids for acute GvHD after reduced-intensity conditioning allogeneic stem cell transplantation

被引：0
作者：
El-Cheikh, J [1 ]
Faucher, C [1 ]
Furst, S [1 ]
de Lavallade, H [1 ]
Blaise, D [1 ]
Mohty, M [1 ]
机构：
[1] Inst J Paoli I Calmettes, F-13009 Marseille, France
来源：
BONE MARROW TRANSPLANTATION | 2006年 / 37卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S185 / S185
页数：1
相关论文
共 50 条
  • [31] Kinetics of CD3+T-cell engraftment correlates with development of acute GvHD and relapse in patients treated with reduced-intensity conditioning allogeneic stem cell transplantation
    Toffoletti, E.
    Patriarca, F.
    Chiarvesio, A.
    Michelutti, A.
    Sperotto, A.
    Cavallin, M.
    Battista, M. L.
    Zaja, F.
    Fanin, R.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S196 - S197
  • [32] Impact of CD8+ T-cell dose on GvhD after antithymocyte globulin (ATG)-based reduced-intensity conditioning (RIC) for allogeneic stem cell transplantation
    Mohty, M
    Faucher, C
    Bagattini, S
    Bardou, V
    Bilger, K
    Gaugler, B
    Chabannon, C
    Ladaique, P
    Lemarie, C
    Vey, N
    Gastaut, JA
    Maraninchi, D
    Olive, D
    Blaise, D
    BONE MARROW TRANSPLANTATION, 2004, 33 : S181 - S181
  • [33] Prophylaxis with mycophenolate mofetil and cyclosporine can decrease the incidence of severe acute GvHD following reduced-intensity conditioning allogeneic stem cell transplantation from matched unrelated donors
    Brissot, E.
    Chevallier, P.
    Guillaume, T.
    Delaunay, J.
    Ayari, S.
    Dubruille, V.
    Le Gouill, S.
    Mahe, B.
    Gastinne, T.
    Blin, N.
    Saulquin, B.
    Moreau, P.
    Harousseau, J. L.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S128 - S129
  • [34] Pharmacokinetics and Buccal Mucosal Concentrations of a 15 Milligram per Kilogram of Body Weight Total Dose of Liposomal Amphotericin B Administered as a Single Dose (15 mg/kg), Weekly Dose (7.5 mg/kg), or Daily Dose (1 mg/kg) in Peripheral Stem Cell Transplant Patients
    Gubbins, Paul O.
    Amsden, Jarrett R.
    McConnell, Scott A.
    Anaissie, Elias J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (09) : 3664 - 3674
  • [35] Phase II Trial of Tandem High-Dose Chemotherapy with Autologous Stem Cell Transplantation Followed by Reduced-Intensity Allogeneic Stem Cell Transplantation for Patients with High-Risk Lymphoma
    Chen, Yi-Bin
    Li, Shuli
    Fisher, David C.
    Driscoll, Jessica
    Del Rio, Candice
    Abramson, Jeremy
    Armand, Philippe
    Barnes, Jeffrey
    Brown, Jennifer
    Cutler, Corey
    El-Jawahri, Areej
    Ho, Vincent T.
    Hochberg, Ephraim
    McAfee, Steven
    Takvorian, Ronald
    Spitzer, Thomas R.
    Antin, Joseph H.
    Soiffer, Robert
    Jacobsen, Eric
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (09) : 1583 - 1588
  • [36] Donor stem cell source does not impact outcome of high-risk acute myeloblastic leukaemia patients after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation
    Fuerst, S.
    Castagna, L.
    Prebet, T.
    El Cheikh, J.
    Faucher, C.
    Vey, N.
    Charbonnier, A.
    Ladaique, P.
    Chabannon, C.
    Blaise, D.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S160 - S160
  • [37] Allogeneic stem cell transplantation in high-risk acute leukemias: Matched pair analysis of reduced intensity conditioning versus standard high-dose conditioning.
    Massenkeil, G
    Heine, F
    Nagy, M
    leCoutre, P
    Mapara, M
    Rosen, O
    Wernecke, KD
    Doerken, B
    Arnold, R
    BLOOD, 2003, 102 (11) : 731A - 731A
  • [38] Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using BLA-identical sibling donors in myelodysplastic syndromes
    Martino, Rodrigo
    Iacobelli, Simona
    Brand, Ronald
    Jansen, Thekla
    van Biezen, Anja
    Finke, Jurgen
    Bacigalupo, Andrea
    Beelen, Dietrich
    Reiffers, Jossy
    Devergie, Agnes
    Alessandrino, Emilie
    Mufti, Ghulam J.
    Barge, Renee
    Sierra, Jorge
    Ruutu, Tapani
    Boogaerts, Marc
    Falda, Michele
    Jouet, Jean-Pierre
    Niederwieser, Dieter
    de Witte, Theo
    BLOOD, 2006, 108 (03) : 836 - 846
  • [39] Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimens
    Bertz, H
    Illerhaus, G
    Veelken, H
    Finke, J
    ANNALS OF ONCOLOGY, 2002, 13 (01) : 135 - 139
  • [40] Low relapse rate in patients receiving adjuvant donor lymphocyte transfusions following allogeneic stem cell transplantation after reduced-intensity conditioning for high-risk AML
    Schleuning, M.
    Schmid, C.
    Koenecke, C.
    Hertenstein, B.
    Baurmann, H.
    Schwerdtfeger, R.
    Kolb, H. J.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S33 - S34
12345